(Reuters) – Pfizer Inc said on Monday it would buy Seagen Inc in a deal valued at $43 billion including debt to expand its portfolio of cancer treatments. (Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty)
Business
Pfizer to buy Seagen in deal valued at $43 billion
(Reuters) – Pfizer Inc said on Monday it would buy Seagen Inc in a deal valued at $43 billion including debt to expand its portfolio of cancer treatments.
(Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty)